METLIFE INC

MetLife insider buying surge signals executive confidence—learn why the pattern matters for investors, valuation, and potential regulatory scrutiny.

Explore how MetLife’s recent insider buying and evolving risk trends—cyber, climate, and regulatory shifts—shape underwriting, claims, and capital strategy.

MetLife insider buying spikes: directors buy shares amid price drop, signalling confidence in digital, global, and regulatory strategies. Explore why it matters.

MetLife insider sales reveal leadership uncertainty—over 40,000 shares dumped in one day—raising questions about future strategy, earnings, and market sentiment.

MetLife insider trades on Feb 24 2026 show routine executive buy‑and‑sell activity, not a market‑moving buying spree—yet still signals management alignment with shareholders.